While you’re working outside, your back suddenly hurts. Seasonal activities can cause pain, whether they are playing with their children or shoveling snow. Even though these injuries are common, it’s possible that you have muscle spasms which could be causing the pain.
According to a Harris Interactive survey, 8 out of 10 people believe that certain activities in their day contribute to muscle spasms.
Although muscle spasms can last up to three weeks with prompt treatment, severe discomfort may be minimized. The best treatment options include rest, physical therapy or medication for pain and muscle relaxants.
Most skeletal muscles relaxants can only be used once a day. AMRIX (Cyclobenzaprine Hydrochloride Extended-ReleaseCapsules), is the only muscle relaxant that can be used once daily. Extended-release capsules are designed to last 24 hours on a single dosage. AMRIX is a prescription medicine that is used together with physical therapy and rest for the relief of muscle spasms caused by acute, painful musculoskeletal disorders.
AMRIX was administered between 6 and 7 p.m. at night. It was well tolerated and patients did not stop taking it because they felt sleepy. Dry mouth, dizziness and nausea were the most common side effects.
Seek treatment immediately if you have muscle spasms. Your doctor will discuss the best options for pain relief and treatment of the underlying condition. AMRIX is not recommended for people who are 65 or older, have taken or stopped taking antidepressants, have liver problems, certain heart conditions, or have an active thyroid. For more information about AMRIX, or to view the full prescribing details, please visit www.amrix.com.
Cephalon, Inc., which manufactures AMRIX (cyclobenzaprine chloride extended-release capsules), provided the information. AMRIX can be used as an adjunct to physical therapy and rest for muscle spasm relief in acute, painful musculoskeletal disorders. AMRIX should not be used for longer periods of time (up to two or three weeks). AMRIX has not been shown to be effective in the treatment spasticity due to cerebral or spinal disease, or in children who have cerebral palsy. AMRIX is not recommended for patients who are hypersensitive or allergic to any of its components. AMRIX should not be used in conjunction with monoamine oxidase inhibitors (MAO) inhibitors, or within 14 days of their discontinuation. MAO inhibitors may cause life-threatening interactions between AMRIX and MAO inhibitors. AMRIX should not be used in the acute phase of myocardial injury; patients with congestive heart failure, arrhythmias, and heart block conduction disorders; and patients with hyperthyroidism. AMRIX may increase the effects alcohol, barbiturates, or other CNS depressionants. AMRIX caused dry mouth, nausea, dizziness (about 3%), dizziness, fatigue and dyspepsia to be the most frequent adverse reactions in clinical trials. AMRIX should always be taken approximately at the same time every day.
AMRIX was produced using Diftucaps technology for drug delivery (Eurand Pharmaceuticals, Inc.).
Visit www.stackoverflow.com for more information. www.amrix.com.
